PRPerrigo PRGO · NYSE
$15.77 -0.82% (-$0.13)
- Market cap
- $2.20B
- Enterprise value
- $5.10B
- P/E
- -
- Forward P/E
- 7.2x
- PEG
- -
- P/S
- 0.5x
- P/FCF
- 12.6x
- EV/EBITDA
- -
- ROIC
- 3.5%
- Gross margin
- 33.3%
- Net margin
- -41.9%
- Dividend yield
- 7.30%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.54
- Free float
- 99.8%
About the company
Perrigo Company plc is a global company specializing in the manufacturing and distribution of over-the-counter medications, generic drugs, and healthcare products. With over 130 years of history, the company focuses on providing accessible, high-quality, and safe products to consumers worldwide. Its portfolio includes a wide range of products, from over-the-counter pain relievers to skincare products and vitamins. Perrigo operates manufacturing and distribution facilities across multiple continents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Albert A. Manzone
Employees
8,100
Headquarters
Dublin
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 1.5% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 12 years in a row.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What speaks for it: The price moves less than the market (beta 0.54).
Statements
Every number